Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-031184

SVP & Chief Scientific Officer sold 3,461 shares at $31.37 ($108,572)

From the SEC's structured data for this filing

Trades in this filing

Doberstein Stephen K · SVP & Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-05-16 Sale : show line 1 in the form −3,461 $31.37 $108,572 95,913 D
Open-market sales · 3,461 sh · avg $31.37 · $108,572
Loading xslF345X03/doc4.xml…